Skip to main content
. 2024 Feb 6;13(4):304. doi: 10.3390/cells13040304

Figure 1.

Figure 1

Treatment of HNSCC and normal tissue cells with KI + IR. (A) Chemical structures of the three kinase inhibitors: the selective mTOR-I Sapanisertib, the dual mTOR-I/DNA-PK-I CC-115, and the selective DNA-PK-I AZD7648. (B) Used cell lines and overview of treatment with endpoints of the different methods in a timeline (created with BioRender.com, accessed on 3 February 2024).